Research Developments in Lymphomas and Chronic Lymphocytic Leukemia (CLL) Presented at Road to a Cure

Nearly 100 participants attended the 2nd Annual “Road to a Cure: The Latest Developments in Blood Cancer Research,” hosted by the Leukemia Research Foundation (LRF) at Cancer Wellness Center in Northbrook, Ill. on Wednesday, May 2. Information about lymphomas, chronic lymphocytic leukemia (CLL), CAR T-cell therapy, and checkpoint blockade therapy were among the topics presented by Dr. Justin Kline, Assistant Professor of Medicine at University of Chicago Medicine.

Doctor Kline's laboratory focuses on overcoming barriers to immune resistance mechanisms in tumors. He develops models in mice to improve immune-mediated rejection of cancer that can be translated into clinical trials for patients with advanced malignancies. His research was supported by the Leukemia Research Foundation during the 2010/2011 funding cycle.

The program was made possible in part by the David Wortman Memorial Fund.

The next LRF patient education program will be held on Saturday, May 19. The Treatment Options for Blood Cancer Patients Conference will include presentations by top experts in the field of hematology/oncology and is free to attend. Information on Conference topics and registration is available on the LRF website at

About The Leukemia Research Foundation (LRF)

The Leukemia Research Foundation, a 4-Star Charity headquartered in Northfield, Ill., is committed to funding research and providing support to people affected by blood cancers. The Leukemia Research Foundation is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. For 72 years, thousands of volunteers and 22 chapters have helped the Foundation raise more than $72 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world, provide patient financial assistance, and offer educational and emotional support for patients and their families.

Leukemia Research Foundation information is available here, or by calling 847-424-0600.


For additional information call:
Carl Alston, Director of Communications
630-202-8294 mobile

Category Tag(s): Press Releases